• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Going Viral: Management of IBD in the Era of the COVID-19 Pandemic.

作者信息

Gutin Liat S, Lam Angela Y, Velayos Fernando S, Santos Stephanie A

机构信息

Department of Gastroenterology and Hepatology, Kaiser Permanente, San Francisco, USA.

Department of Gastroenterology and Hepatology, Kaiser Permanente, 3600 Broadway, 2nd Floor, Oakland, CA, 94611, USA.

出版信息

Dig Dis Sci. 2020 Jun;65(6):1571-1575. doi: 10.1007/s10620-020-06299-y.

DOI:10.1007/s10620-020-06299-y
PMID:32363528
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7196441/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8391/7196441/e1685b367aaf/10620_2020_6299_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8391/7196441/c9f498e2b4a0/10620_2020_6299_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8391/7196441/a5a1c743f617/10620_2020_6299_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8391/7196441/e1685b367aaf/10620_2020_6299_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8391/7196441/c9f498e2b4a0/10620_2020_6299_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8391/7196441/a5a1c743f617/10620_2020_6299_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8391/7196441/e1685b367aaf/10620_2020_6299_Fig3_HTML.jpg

相似文献

1
Going Viral: Management of IBD in the Era of the COVID-19 Pandemic.
Dig Dis Sci. 2020 Jun;65(6):1571-1575. doi: 10.1007/s10620-020-06299-y.
2
Onset of ulcerative colitis during SARS-CoV-2 infection.2019冠状病毒病感染期间溃疡性结肠炎的发病
Dig Liver Dis. 2020 Nov;52(11):1228-1229. doi: 10.1016/j.dld.2020.06.003. Epub 2020 Jun 11.
3
Inflammatory Bowel Disease Management During the Coronavirus-19 Outbreak: A Survey From the European Crohn's and Colitis Organization.2019冠状病毒病疫情期间炎症性肠病的管理：来自欧洲克罗恩病和结肠炎组织的一项调查
Gastroenterology. 2020 Jul;159(1):14-19.e3. doi: 10.1053/j.gastro.2020.04.059. Epub 2020 Apr 30.
4
COVID-19-related Acute Respiratory Distress Syndrome: Not So Atypical.新型冠状病毒肺炎相关急性呼吸窘迫综合征：并非那么不典型。
Am J Respir Crit Care Med. 2020 Aug 15;202(4):622-624. doi: 10.1164/rccm.202004-1423LE.
5
Management of Patients With Crohn's Disease and Ulcerative Colitis During the Coronavirus Disease-2019 Pandemic: Results of an International Meeting.2019冠状病毒病大流行期间克罗恩病和溃疡性结肠炎患者的管理：一次国际会议的结果
Gastroenterology. 2020 Jul;159(1):6-13.e6. doi: 10.1053/j.gastro.2020.04.002. Epub 2020 Apr 6.
6
Priority plan for invasive cardiac electrophysiology procedures during the coronavirus disease 2019 (COVID-19) pandemic.2019年冠状病毒病（COVID-19）大流行期间侵入性心脏电生理手术的优先计划。
J Cardiovasc Electrophysiol. 2020 Jun;31(6):1255-1258. doi: 10.1111/jce.14478. Epub 2020 Apr 23.
7
A fatal case of COVID-19 pneumonia occurring in a patient with severe acute ulcerative colitis.一名患有严重急性溃疡性结肠炎的患者发生了致命的新冠肺炎肺炎病例。
Gut. 2020 Jun;69(6):1148-1149. doi: 10.1136/gutjnl-2020-321183. Epub 2020 Apr 3.
8
Defining Association between COVID-19 and the Multisystem Inflammatory Syndrome in Children through the Pandemic.通过疫情界定新冠病毒疾病（COVID-19）与儿童多系统炎症综合征之间的关联。
J Korean Med Sci. 2020 Jun 8;35(22):e204. doi: 10.3346/jkms.2020.35.e204.
9
The COVID-19 Pandemic: Clinical Information for Ophthalmologists.2019年冠状病毒病大流行：眼科医生的临床信息
Turk J Ophthalmol. 2020 Apr 29;50(2):59-63. doi: 10.4274/tjo.galenos.2020.29805.
10
Adaptations to the British Society of Gastroenterology guidelines on the management of acute severe UC in the context of the COVID-19 pandemic: a RAND appropriateness panel.在 COVID-19 大流行背景下对英国胃肠病学会关于急性重度 UC 管理指南的适应性调整：一个 RAND 适宜性小组。
Gut. 2020 Oct;69(10):1769-1777. doi: 10.1136/gutjnl-2020-321927. Epub 2020 Jun 8.

引用本文的文献

1
Comorbidities, Associated Diseases, and Risk Assessment in COVID-19-A Systematic Review.合并症、相关疾病和 COVID-19 风险评估——系统综述。
Int J Clin Pract. 2022 Oct 31;2022:1571826. doi: 10.1155/2022/1571826. eCollection 2022.
2
Transmembrane serine protease 2 and angiotensin-converting enzyme 2 anti-inflammatory receptors for COVID-19/inflammatory bowel diseases treatment.跨膜丝氨酸蛋白酶 2 和血管紧张素转换酶 2 抗炎受体治疗 COVID-19/炎症性肠病。
World J Gastroenterol. 2021 Dec 14;27(46):7943-7955. doi: 10.3748/wjg.v27.i46.7943.
3
A machine learning approach identifies 5-ASA and ulcerative colitis as being linked with higher COVID-19 mortality in patients with IBD.

本文引用的文献

1
Clinical Characteristics of COVID-19 Patients With Digestive Symptoms in Hubei, China: A Descriptive, Cross-Sectional, Multicenter Study.中国湖北有消化道症状的 COVID-19 患者的临床特征：一项描述性、横断面、多中心研究。
Am J Gastroenterol. 2020 May;115(5):766-773. doi: 10.14309/ajg.0000000000000620.
2
AGA Clinical Practice Update on Management of Inflammatory Bowel Disease During the COVID-19 Pandemic: Expert Commentary.美国胃肠病学会关于2019冠状病毒病大流行期间炎症性肠病管理的临床实践更新：专家评论
Gastroenterology. 2020 Jul;159(1):350-357. doi: 10.1053/j.gastro.2020.04.012. Epub 2020 Apr 10.
3
Diarrhea During COVID-19 Infection: Pathogenesis, Epidemiology, Prevention, and Management.
机器学习方法表明，5-氨基水杨酸和溃疡性结肠炎与 IBD 患者 COVID-19 死亡率升高相关。
Sci Rep. 2021 Aug 13;11(1):16522. doi: 10.1038/s41598-021-95919-2.
4
How to manage inflammatory bowel disease during the COVID-19 pandemic: A guide for the practicing clinician.在 COVID-19 大流行期间如何管理炎症性肠病：临床医生实用指南。
World J Gastroenterol. 2021 Mar 21;27(11):1022-1042. doi: 10.3748/wjg.v27.i11.1022.
5
Why Do Immunosuppressed Patients with Inflammatory Bowel Disease Not Seem to Be at a Higher Risk of COVID-19?为什么炎症性肠病免疫抑制患者似乎没有更高的 COVID-19 风险？
Dig Dis Sci. 2021 Sep;66(9):2855-2864. doi: 10.1007/s10620-020-06624-5. Epub 2020 Oct 19.
6
Should We Be Screening for SARS-CoV-2 in IBD Patients Before Initiation of Biologic Therapy?在炎症性肠病（IBD）患者开始生物治疗前，我们是否应该对其进行新型冠状病毒2（SARS-CoV-2）筛查？
Inflamm Bowel Dis. 2021 Jan 19;27(2):291-294. doi: 10.1093/ibd/izaa173.
新冠病毒感染期间的腹泻：发病机制、流行病学、预防和管理。
Clin Gastroenterol Hepatol. 2020 Jul;18(8):1663-1672. doi: 10.1016/j.cgh.2020.04.001. Epub 2020 Apr 8.
4
Uneventful Course in Patients With Inflammatory Bowel Disease During the Severe Acute Respiratory Syndrome Coronavirus 2 Outbreak in Northern Italy.意大利北部严重急性呼吸综合征冠状病毒2疫情期间炎症性肠病患者的平稳病程
Gastroenterology. 2020 Jul;159(1):371-372. doi: 10.1053/j.gastro.2020.03.062. Epub 2020 Apr 2.
5
Viral screening before initiation of biologics in patients with inflammatory bowel disease during the COVID-19 outbreak.在新冠疫情期间，对炎症性肠病患者使用生物制剂前进行病毒筛查。
Lancet Gastroenterol Hepatol. 2020 Jun;5(6):525. doi: 10.1016/S2468-1253(20)30085-6. Epub 2020 Mar 25.
6
Are Patients with Inflammatory Bowel Disease at Increased Risk for Covid-19 Infection?炎症性肠病患者感染 COVID-19 的风险是否增加？
J Crohns Colitis. 2020 Sep 16;14(9):1334-1336. doi: 10.1093/ecco-jcc/jjaa061.
7
Epidemiological, clinical and virological characteristics of 74 cases of coronavirus-infected disease 2019 (COVID-19) with gastrointestinal symptoms.74 例伴有胃肠道症状的 2019 年冠状病毒病（COVID-19）患者的流行病学、临床和病毒学特征。
Gut. 2020 Jun;69(6):1002-1009. doi: 10.1136/gutjnl-2020-320926. Epub 2020 Mar 24.
8
Don't Overlook Digestive Symptoms in Patients With 2019 Novel Coronavirus Disease (COVID-19).不要忽视2019新型冠状病毒病（COVID-19）患者的消化症状。
Clin Gastroenterol Hepatol. 2020 Jun;18(7):1636-1637. doi: 10.1016/j.cgh.2020.03.043. Epub 2020 Mar 20.
9
COVID-19 and the liver: little cause for concern.新冠病毒与肝脏：无需过度担忧。
Lancet Gastroenterol Hepatol. 2020 Jun;5(6):529-530. doi: 10.1016/S2468-1253(20)30084-4. Epub 2020 Mar 20.
10
Detection of SARS-CoV-2 in Different Types of Clinical Specimens.SARS-CoV-2 在不同类型临床标本中的检测。
JAMA. 2020 May 12;323(18):1843-1844. doi: 10.1001/jama.2020.3786.